PennyMac Financial Services (PFSI)
(Delayed Data from NYSE)
$99.91 USD
+0.61 (0.61%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $99.87 -0.04 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$99.91 USD
+0.61 (0.61%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $99.87 -0.04 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Zacks News
PennyMac Financial (PFSI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
PennyMac Financial (PFSI) closed the most recent trading day at $28.87, moving +0.42% from the previous trading session.
Top Ranked Value Stocks to Buy for April 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 28th
Are Investors Undervaluing PennyMac Financial (PFSI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: Livongo Health, Karuna Therapeutics, Sprouts Farmers Market, PennyMac Financial Services and Strategic Education
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Livongo Health, Karuna Therapeutics, Sprouts Farmers Market, PennyMac Financial Services and Strategic Education
5 Top Mid-Cap Stocks Surging Despite Coronavirus Concerns
by Nalak Das
Apart from the large-cap specific three major stock indexes, the mid-cap specific S&P 400 also witnessed a a rally since Mar 23.
Top Ranked Value Stocks to Buy for April 24th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 24th
Top Ranked Value Stocks to Buy for April 20th
by Tirthankar Chakraborty
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 20th
Will PennyMac (PFSI) Gain on Rising Earnings Estimates?
by Zacks Equity Research
PennyMac (PFSI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Top Ranked Value Stocks to Buy for April 14th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 14th
Should Value Investors Buy PennyMac Financial (PFSI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Value Stocks to Buy for April 8th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 8th
Will PennyMac (PFSI) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
PennyMac (PFSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks.com featured highlights include: DaVita, EchoStar and PennyMac Financial Services
by Zacks Equity Research
Zacks.com featured highlights include: DaVita, EchoStar and PennyMac Financial Services
3 Momentum Anomaly Stocks to Consider Amid Coronavirus Woes
by Zacks Equity Research
These fast movers are currently witnessing a short-term pullback in price as COVID-19 pandemonium batters market. So, this could essentially be a solid entry point for garnering profits.
5 Must-Buy High-Yielding Mid-Cap Stocks to Tap Market Rally
by Nalak Das
Meanwhile, it looks like that the panic selling of equities by market participants ??? popularly called as selling everything ??? is over.
Powerful Proof Anyone Can Invest for an Early Retirement - March 26, 2020
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
Top Ranked Value Stocks to Buy for March 26th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, March 26th
Is PennyMac Financial (PFSI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bank of Hawaii (BOH) Displays Organic Growth: Time to Hold?
by Zacks Equity Research
Bank of Hawaii's (BOH) expenses witness an increase despite its organic growth efforts, and rising loans and deposits.
Why PennyMac Financial (PFSI) Stock Might be a Great Pick
by Zacks Equity Research
PennyMac Financial (PFSI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Here's Why You Should Add Virtu Financial to Your Portfolio
by Zacks Equity Research
Driven by strong fundamentals and good growth prospects, Virtu Financial (VIRT) stock looks like an attractive investment option now.
Rising Expenses Hurt Comerica's (CMA) Bottom-line Growth
by Zacks Equity Research
Rising restructuring-related and compensation expenses keep Comerica's (CMA) costs high. Also, its substantial exposure to commercial loans, which reflects a lack of diversification, is concerning.
UBS Group (UBS) to Brave Coronavirus Impacts with Low Losses
by Zacks Equity Research
UBS Group (UBS) expects to deliver lower losses despite facing woes from the coronavirus outbreak.
3 Stocks Witnessing Momentum Anomaly Amid Coronavirus Crisis
by Zacks Equity Research
These fast movers are currently witnessing a short-term pullback in price, as COVID-19 pandemic rattles market. So, this could essentially be a great entry point for higher returns.
Signs That Your Trading Will Ruin Your Retirement - March 19, 2020
by Zacks Equity Research
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.